With the goal of translating the greatest advances in science and technology into clinically validated health products that work, Elysium Health has designed Basis to help support various cellular functions.
Elysium Health is a health startup that was founded by Dr. Leonard Guarente in 2014. Dr. Guarente serves as the director of The Paul F. Glenn Center for Biology of Aging at MIT in addition to his duties as the chief scientist of Elysium Health. He has conducted significant research on the genetic and molecular causes of aging.
— Elysium Health (@ElysiumHQ) April 10, 2018
Basis was created based on 25 years of aging research. Elysium Health performed a clinical trial in 2016 to ensure that Basis works as intended and frequently puts the supplement through third-party quality testing. The results of the trial showed that taking Basis daily over the course of several weeks increased levels of NAD+ in humans by an average of 40%. The results of the study trial were published in the science journal npj: Aging and Mechanisms of Disease.
Basis increases NAD+ levels to support overall cellular health. NAD+ is a coenzyme that is essential to cellular functions like energy creation, circadian rhythms, and DNA protection. As we age, our levels of NAD+ decline naturally and those functions break down. By increasing and sustaining levels of NAD+, Basis helps support those functions and our cellular health.
Basis is available in a variety of subscriptions. A standard monthly subscription costs $50 per month. A six-month subscription costs $270 ($45 per month). Basis is also available as a one-time purchase for $60 per bottle. For a complete list of options, visit Elysium Health’s website.
Elysium Health works with world-class scientists from prestigious institutions such as Harvard, Oxford, and Cambridge. The goal of the company is to help people live healthier for longer.
Elysium Health is developing new products that focus on the microbiome, cognitive health, skin health, muscle function, and circadian rhythms. These products are in various stages of pre-clinical and clinical trials.